ASP Isotopes Founder Paul Mann To Return As CEO On January 19, 2026, After Health-Related Leave; Interim CEO Robert Ainscow To Resume COO-Only Role
Benzinga Newsdesk 11 months ago
NewsManagement
ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries,
ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that, effective January 19, 2026, Paul Mann, the founder and Executive Chairman of ASP Isotopes, will resume his role as the Company's Chief Executive Officer and continue as Executive Chairman.
On September 29, 2025, it was announced that Mr. Mann would be taking a temporary leave of absence from his Chief Executive Officer duties for health reasons, and that the Company's Board of Directors had appointed Robert Ainscow, the Company's Chief Operating Officer, to serve as Interim Chief Executive Officer, in addition to his current duties. Mr. Mann is now able to travel again and he will resume full day-to-day CEO duties as of January 19, 2026.